Bio-Medical Research Limited was set up on Tuesday the 19th of December 1989. Their current partial address is Dublin 2, and the company status is Liquidation(Receivership). The company's current directors have been the director of 17 other Irish companies between them; 11 of which are now closed. Bio-Medical Research Limited has 1 shareholder. This Irish company shares its Eircode with at least 1,117 other companies.
| Company Name: | Bio-Medical Research Limited | |
| Company Status: | LIQUIDATION(RECEIVERSHIP) | |
| RiskWatch | COURT ORDER LIQUIDATION Court Order Date 02/06/2022 | |
| RiskWatch | HIGH COURT APPOINTMENT Court Order Date 16/03/2022 | |
| RiskWatch | HIGH COURT PETITION Presentation Date 07/03/2022 | |
| Company Address: | Grant Thornton, 13-18 City Quay, Dublin, Dublin 2 | |
| Telephone: | +353 (0)91 774 300 | |
| Key Executive: | Mr Minogue | |
| Company Size: | Log-In To View | |
| Disclaimer | Other Details | |
|---|---|---|
| Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us. | ||
Mr Minogue is a Company Director of Bio-Medical Research Limited since 1994 and a listed Director of 8 other companies.
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
The latest documents filed with the Companies Registration Office for Bio-Medical Research Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form E9: Receiver`s Abstract | 01/06/2024 | 17/07/2024 | Join Up | |
| Form E3: Liquidator`s Accounts of Acts & Dealings | 01/06/2024 | 02/07/2024 | Join Up | |
| Liquidator`s Report of Acts & Dealings | 01/06/2024 | 02/07/2024 | Join Up | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 01/06/2024 | 07/06/2024 | Join Up | |
| Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up | 01/12/2023 | 11/12/2023 | Join Up | |
| THIS COMPANY HAS 290 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
View the Latest Credit Report and Credit Limit on Bio-Medical Research Limited.
| Company Status: | Liquidation(Receivership) | |
| RiskWatch | COURT ORDER LIQUIDATION Court Order Date 02/06/2022 | |
| RiskWatch | HIGH COURT APPOINTMENT Court Order Date 16/03/2022 | |
| RiskWatch | HIGH COURT PETITION Presentation Date 07/03/2022 | |
| Latest Credit Movement: |  | |
| Date of Last Movement: | 28/03/2023 | |
| Latest Accounts Filed: | 08/12/2021 | |
| Report Based on Accounts: | 31/12/2020 | |
| Next Set of Accounts Due: | 30/09/2022 | |
| Overdue: | Yes | |
| Credit Score: | Join-Up to View | |
To View the latest Credit Rating or Credit Limit on Bio-Medical Research Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Satisfy due diligence requirements on Bio-Medical Research Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Bio-Medical Research Limited and Anti-Money Laundering checks (AML checks) on Bio-Medical Research Limited
| Company Type: | CLG - Company Limited By Guarantee |
| Number of Shareholders: | 1 |
Log-in now to run Due Diligence checks and Compliance checks on Bio-Medical Research Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
More people choose Vision-net over any other search service... ask us why?
20/08/2024
The number of consumer judgements in H1 2024 has seen a significant increase, when compared to the same period in 2023, 56% up...
13/08/2024
Today's world is interconnected, and companies have expanded their operations, options, and work across countries, and continents in a way never seen before...
06/08/2024
A key pillar of the CSRD requires businesses to start reporting on their ESG activities...
09/07/2024
A politically exposed person (PEP) is an individual who has been entrusted with a prominent public function...
